The VACCINES Act: Deciphering Vaccine Hesitancy in the Time of COVID-19

Abstract Since the COVID-19 pandemic first hit Wuhan, China, in December 2019, scientists have been racing to develop and test novel vaccines to protect against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The speed of scientific discovery related to COVID-19 is unprecedented. With...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical infectious diseases 2020-07, Vol.71 (15), p.703-705
Hauptverfasser:	McAteer, John, Yildirim, Inci, Chahroudi, Ann
Format:	Artikel
Sprache:	eng
Schlagworte:	Betacoronavirus - immunology Coronavirus Infections - immunology Coronavirus Infections - prevention & control Coronavirus Infections - psychology COVID-19 COVID-19 Vaccines Humans Immunization Programs - legislation & jurisprudence Invited Legislation, Drug Pandemics - prevention & control Patient Education as Topic - legislation & jurisprudence Pneumonia, Viral - immunology Pneumonia, Viral - prevention & control Pneumonia, Viral - psychology SARS-CoV-2 United States - epidemiology Vaccination Refusal - psychology Viral Vaccines - pharmacology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Abstract Since the COVID-19 pandemic first hit Wuhan, China, in December 2019, scientists have been racing to develop and test novel vaccines to protect against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The speed of scientific discovery related to COVID-19 is unprecedented. With several vaccine candidates already being tested in clinical trials, we pose the question: what will the vaccine hesitant do in the face of this pandemic?
ISSN:	1058-4838 1537-6591
DOI:	10.1093/cid/ciaa433